Stay updated on Clinical Trial: Ixazomib Combo in Relapsed Multiple Myeloma

Sign up to get notified when there's something new on the Clinical Trial: Ixazomib Combo in Relapsed Multiple Myeloma page.
Latest website image capture
Clouds background image

Latest updates to the Clinical Trial: Ixazomib Combo in Relapsed Multiple Myeloma page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page footer now displays revision v3.8.0 instead of v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-31T14:06:20.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A sitewide NIH notice announces a transition in terminology, stating that the agency is using “Super Intelligence” in place of “Artificial Intelligence” during the transition.
    Difference
    0.9%
    Check dated 2026-10-24T13:33:44.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-17T13:38:36.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-10T13:39:15.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The page history now includes a new revision entry labeled v3.7.0, and the previous revision v3.6.6 was removed from the history.
    Difference
    0.1%
    Check dated 2026-09-19T19:12:39.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    The study record history now includes a new revision entry v3.6.6, updating the page to the latest release. The prior revision v3.6.5 is superseded in the history.
    Difference
    0.1%
    Check dated 2026-08-29T18:53:12.000Z thumbnail image

Stay in the know with updates to Clinical Trial: Ixazomib Combo in Relapsed Multiple Myeloma

Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Ixazomib Combo in Relapsed Multiple Myeloma page.